UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial

Annals of oncology, 2012-08, Vol.23 (8), p.2020-2027

2012

Volltextzugriff (PDF)

Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial

European journal of cancer (1990), 2013-09, Vol.49 (13), p.2806-2814

2013

Volltextzugriff (PDF)

Traitements adjuvants du cancer du sein

Oncologie (Paris), 2007-08, Vol.9 (7-8), p.553-554

Mefti, F.

2007

Volltextzugriff (PDF)

Results from an observational study (NORA) with oral Navelbine in metastatic breast cancer: A sub-analysis in elderly patients

Journal of geriatric oncology, 2012-10, Vol.3, p.S41-S42

2012

Volltextzugriff (PDF)

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

British journal of cancer, 2012-02, Vol.106 (4), p.673-677

2012

Volltextzugriff (PDF)

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

Annals of oncology, 2012-02, Vol.23 (2), p.346-352

2012

Volltextzugriff (PDF)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

The Lancet (British edition), 2019-06, Vol.393 (10191), p.2591-2598

2019

Volltextzugriff (PDF)

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

European journal of cancer supplements, 2009, Vol.7 (2), p.259-259

2009

Volltextzugriff (PDF)

Traitements adjuvants du cancer du sein

Oncologie (Paris, France), 2008-08, Vol.10 (7-8), p.504-506

Mefti, F.

2008

Volltextzugriff (PDF)

First-line chemoimmunotherapy in metastatic breast carcinoma: Effect of a combination of paclitaxel and LAG-3-ig (IMP321), a novel MHC class II agonist, on T-cell responses and antitumor activity

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2513-2513

2010

Volltextzugriff (PDF)

Vinflunine (Vfl) Plus Capecitabine (Cape) for Advanced Breast Cancer (Abc) Previously Treated with or Resistant to Anthracycline and Resistant to Taxane : a Phase 3 Study Versus Capecitabine

Annals of oncology, 2014-09, Vol.25, p.iv119

2014

Volltextzugriff (PDF)

358PDVINFLUNINE (VFL) PLUS CAPECITABINE (CAPE) FOR ADVANCED BREAST CANCER (ABC) PREVIOUSLY TREATED WITH OR RESISTANT TO ANTHRACYCLINE AND RESISTANT TO TAXANE : A PHASE 3 STUDY VERSUS CAPECITABINE

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv119-iv119

2014

Volltextzugriff (PDF)

Use of Liposomal Doxorubicin for Metastatic Breast Cancer Management Across Europe: Results of Eos (European Observatory & Survey)

Annals of oncology, 2014-09, Vol.25, p.iv130

2014

Volltextzugriff (PDF)

396PUSE OF LIPOSOMAL DOXORUBICIN FOR METASTATIC BREAST CANCER MANAGEMENT ACROSS EUROPE: RESULTS OF EOS (EUROPEAN OBSERVATORY & SURVEY)

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv130-iv131

2014

Volltextzugriff (PDF)

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.P5-P5-19-01

2011

Volltextzugriff (PDF)

Health-related quality of life (HRQL) and progression-free survival (PFS) in patients with recurrent ovarian cancer: Results from the CALYPSO trial

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.5044-5044

2010

Volltextzugriff (PDF)

Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.9122-9122

2011

Volltextzugriff (PDF)

Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.3017-3017

2009

Volltextzugriff (PDF)

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study

BMC cancer, 2005-11, Vol.5 (1), p.151-151, Article 151

2005

Volltextzugriff (PDF)

Health-related quality of life in recurrent platinum-sensitive ovarian cancer-results from the CALYPSO trial

Annals of oncology, 2012-08, Vol.23 (8), p.2020

2012

Volltextzugriff (PDF)

GEP01: A phase I study of lapatinib (L) and vinorelbine (VNR) in HER2 overexpressing (HER2+) locally advanced or metastatic breast cancer (LAMBC) patients (pts): A FNCLCC Group of early phase trials study

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.1051-1051

2009

Volltextzugriff (PDF)

Cancers du sein métastatiques

Oncologie (Paris, France), 2005-08, Vol.7 (S4), p.ns25-ns26

2005

Volltextzugriff (PDF)

Response of Mediterranean Tall Fescue Cultivars to Contrasting Agricultural Environments and Implications for Selection

Journal of agronomy and crop science (1986), 2011-02, Vol.197 (1), p.12-20

2011

Volltextzugriff (PDF)

Statistical analysis of solar measurements in Algeria using beta distributions

Renewable energy, 2002-05, Vol.26 (1), p.47-67

2002

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(30)
Französisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health-related quality of life in recurrent platinum-sensitive ovarian cancer—results from the CALYPSO trial

Impact of geriatric risk factors on pegylated liposomal doxorubicin tolerance and efficacy in elderly metastatic breast cancer patients: Final results of the DOGMES multicentre GINECO trial

Traitements adjuvants du cancer du sein

Results from an observational study (NORA) with oral Navelbine in metastatic breast cancer: A sub-analysis in elderly patients

Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2

Weekly paclitaxel as a single agent or in combination with carboplatin or weekly topotecan in patients with resistant ovarian cancer: the CARTAXHY randomized phase II trial from Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO)

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial

5000 A 3-arm randomised phase II study of oral vinorelbine (NVBo) plus capecitabine (X) versus NVBo and X in sequential versus docetaxel (D) plus X in patients with metastatic breast cancer (MBC) previously treated with anthracyclines

Traitements adjuvants du cancer du sein

First-line chemoimmunotherapy in metastatic breast carcinoma: Effect of a combination of paclitaxel and LAG-3-ig (IMP321), a novel MHC class II agonist, on T-cell responses and antitumor activity

Vinflunine (Vfl) Plus Capecitabine (Cape) for Advanced Breast Cancer (Abc) Previously Treated with or Resistant to Anthracycline and Resistant to Taxane : a Phase 3 Study Versus Capecitabine

358PDVINFLUNINE (VFL) PLUS CAPECITABINE (CAPE) FOR ADVANCED BREAST CANCER (ABC) PREVIOUSLY TREATED WITH OR RESISTANT TO ANTHRACYCLINE AND RESISTANT TO TAXANE : A PHASE 3 STUDY VERSUS CAPECITABINE

Use of Liposomal Doxorubicin for Metastatic Breast Cancer Management Across Europe: Results of Eos (European Observatory & Survey)

396PUSE OF LIPOSOMAL DOXORUBICIN FOR METASTATIC BREAST CANCER MANAGEMENT ACROSS EUROPE: RESULTS OF EOS (EUROPEAN OBSERVATORY & SURVEY)

P5-19-01: Final Results of a Three-Arm Randomised Phase II Study of Oral Vinorelbine Plus Capecitabine Versus Oral Vinorelbine and Capecitabine in Sequence Versus Docetaxel Plus Capecitabine in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclines

Health-related quality of life (HRQL) and progression-free survival (PFS) in patients with recurrent ovarian cancer: Results from the CALYPSO trial

Impact of geriatric vulnerability parameters on pegylated liposomal doxorubicin (PLD) tolerance and outcome in elderly patients with metastatic breast cancer: Results of the DOGMES multicenter phase II GINECO trial

Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer

First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study

Health-related quality of life in recurrent platinum-sensitive ovarian cancer-results from the CALYPSO trial

GEP01: A phase I study of lapatinib (L) and vinorelbine (VNR) in HER2 overexpressing (HER2+) locally advanced or metastatic breast cancer (LAMBC) patients (pts): A FNCLCC Group of early phase trials study

Cancers du sein métastatiques

Response of Mediterranean Tall Fescue Cultivars to Contrasting Agricultural Environments and Implications for Selection

Statistical analysis of solar measurements in Algeria using beta distributions

Suchergebnisse filtern